Nutrient absorption reduction

“Nutrient absorption reduction” is not a distinct molecular target but rather a physiological outcome or process in which the absorption of nutrients from the gut into systemic circulation is decreased. Nutrient absorption in the intestines is mediated by a wide array of transport proteins (e.g., SGLT1 for glucose, peptide transporters, fatty acid transporters), cellular mechanisms (diffusion, facilitated diffusion, active transport), and digestive enzymes[1][2][3][4][5][6]. The process can be intentionally targeted by some drugs to treat conditions like obesity or diabetes, or it can be a pathological consequence of gut disease. However, “Nutrient absorption reduction” is not a specific molecular entity (such as a receptor, enzyme, or transporter)—rather, interventions that target specific molecules or pathways (for instance, lipase for fat, SGLT1 for glucose, etc.) will result in nutrient absorption reduction as an effect. As such, it is not appropriate to treat “Nutrient absorption reduction” as a canonical target: it is a functional outcome of various molecular interventions, not a discrete molecular target itself[1][2][4][5].

Other names

Nutrient uptake reductionImpaired nutrient absorptionDecreased nutrient absorption

Inhibition of digestive enzymes (e.g., lipase, amylase inhibitors); Inhibition/blockade of intestinal transport proteins; Delayed gastric emptying; Physical sequestration of nutrients (e.g., fiber binding or bile acid sequestration)